ent-Trachylobane acid
ID: ALA1083997
PubChem CID: 11594850
Max Phase: Preclinical
Molecular Formula: C20H28O3
Molecular Weight: 316.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
ID: ALA1083997
PubChem CID: 11594850
Max Phase: Preclinical
Molecular Formula: C20H28O3
Molecular Weight: 316.44
Molecule Type: Small molecule
Associated Items:
Synonyms: Ent-Trachylobane Acid | ent-Trachylobane acid|CHEMBL1083997
Canonical SMILES: CC1(C)C(=O)CC[C@]2(C)[C@@H]1CC[C@@]13CC4[C@@H](C[C@H]12)[C@]4(C(=O)O)C3
Standard InChI: InChI=1S/C20H28O3/c1-17(2)13-4-7-19-9-12-11(20(12,10-19)16(22)23)8-14(19)18(13,3)6-5-15(17)21/h11-14H,4-10H2,1-3H3,(H,22,23)/t11-,12?,13-,14+,18-,19+,20-/m1/s1
Standard InChI Key: LWVHCBVUOMLPIW-LAYRKWIQSA-N
Molfile:
RDKit 2D 26 30 0 0 0 0 0 0 0 0999 V2000 -2.8897 -0.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8897 -1.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1772 -1.9031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1772 -0.2486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4603 -0.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4592 -1.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7462 -1.9021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0297 -1.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7483 -0.2477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0322 -0.6595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6786 -0.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6795 0.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0368 0.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7538 0.5761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6021 -1.9031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5972 -2.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7745 -2.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4683 0.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4602 -2.4918 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.6175 0.2468 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1.3917 0.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1043 0.5787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3913 1.8124 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4492 0.0576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2593 0.4735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2971 0.0244 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 9 14 1 0 10 11 1 1 12 11 1 0 13 12 1 0 13 14 1 0 2 3 1 0 2 15 2 0 5 9 1 0 3 16 1 0 6 7 1 0 3 17 1 0 7 8 1 0 5 18 1 6 8 10 1 0 6 19 1 1 9 10 1 0 9 20 1 1 3 6 1 0 5 4 1 0 12 21 1 1 5 6 1 0 21 22 1 0 21 23 2 0 1 2 1 0 10 24 1 0 1 4 1 0 25 24 1 0 13 25 1 0 12 25 1 0 13 26 1 6 M END
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.44 | Molecular Weight (Monoisotopic): 316.2038 | AlogP: 3.91 | #Rotatable Bonds: 1 |
Polar Surface Area: 54.37 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.54 | CX Basic pKa: ┄ | CX LogP: 3.72 | CX LogD: 0.95 |
Aromatic Rings: ┄ | Heavy Atoms: 23 | QED Weighted: 0.80 | Np Likeness Score: 3.54 |
1. Allen JG, Fotsch C, Babij P.. (2010) Emerging targets in osteoporosis disease modification., 53 (11): [PMID:20218623] [10.1021/jm9018756] |
Source(1):